Histone H1 inhibits the proliferation of MCF 7 and MDA MB 231 human breast cancer cells

Cell Biology International

Volumn 30, Issue 4, 2006, Pages 326-331

  Vani, G ^a   Vanisree, A J ^a   Shyamaladevi, C S ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

Apoptosis; Breast cancer; Histone H1; MCF 7 cells; MDA MB 231; Ornithine decarboxylase

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ACRIDINE ORANGE; ANTINEOPLASTIC AGENT; CARBON 14; DNA FRAGMENT; ESTROGEN RECEPTOR; HISTONE H1; ORNITHINE; ORNITHINE DECARBOXYLASE; PROPIDIUM IODIDE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; ASSAY; BREAST CANCER; CANCER CELL CULTURE; CELL LINE; CELL PROLIFERATION; COLONY FORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DNA DETERMINATION; ENZYME ACTIVITY; ENZYME INHIBITION; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; PROTEIN FUNCTION; STAINING; STATISTICAL SIGNIFICANCE;

BREAST NEOPLASMS; CELL PROLIFERATION; CELL SURVIVAL; DNA FRAGMENTATION; FEMALE; HISTONES; HUMANS; ORNITHINE DECARBOXYLASE; TUMOR CELLS, CULTURED;

EID: 33645992434     PISSN: 10656995     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellbi.2005.12.004     Document Type: Article

References (51)

1. Abakushin D.N., Zamulaeva I.A., and Poverenny A.M. Histones evoke thymocyte death in vitro; histone-binding immunoglobulins decrease their cytotoxicity. Biochemistry (Mosc) 64 (1999) 693-698
2. Bardon S., Vignon F., Montcourrier P., and Rochefort H. Steroid receptor-mediated cytotoxicity of an antiestrogen and an antiprogestin in breast cancer cells. Cancer Res 47 (1987) 1441-1448
3. 14C] carboxyl-labeled amino acids. Anal Biochem 84 (1987) 638-641
4. Canizares F., Salinas J., de las Heras M., Diaz J., Tovar I., Martinez P., et al. Prognostic value of ornithine decarboxylase and polyamines in human breast cancer: correlation with clinicopathologic parameters. Clin Cancer Res 5 (1999) 2035-2041
5. Casero Jr. R.A., and Pegg A.E. Spermidine - spermine N1-acetyltransferase - turning point in polyamine metabolism. FASEB J 7 (1993) 653-661
6. Cheung E., Zarifyan A.S., and Kraus W.L. Histone H1 represses estrogen receptor α transcriptional activity by selectively inhibiting receptor mediated transcription initiation. Mol Cell Biol 22 (2002) 2463-2471
7. Class R., Lindman S., Fassbender C., Leinenbach H.P., Rawer S., Emrich J.G., et al. Histone H1 suppresses tumour growth of leukemia cells in vitro, ex vivo and in an animal model suggesting extracellular functions of histones. Am J Clin Oncol 19 (1996) 522-531
8. Comsa J., Leonhardt H., and Weckerly H. Hormonal coordination of the immune response. [Review]. Rev Physiol Biochem Pharmacol 92 (1982) 116-191
9. 12-bis(ethyl)spermine. Cancer Res 53 (1993) 2071-2075
10. Duke R.C., and Cohen J.J. Morphological and biochemical assays of apoptosis. In: Colgan J.E., Kruisbeek A.M., Margulies D.H., Shevach E.M., and Strober W. (Eds). Current protocols in immunology (1992), Greene Publishing and Wiley Interscience, New York 3.17.11-3.17.16
11. Elgin S.C.R., and Weintraub H. Chromosomal proteins and chromatin structure. Ann Rev Biochem 44 (1975) 725-774
12. Essmann F., Ingo H., Engels H.I., Totzke G., Schulze-Osthoff K., and Jänicke R.U. Apoptosis resistance of MCF-7 breast carcinoma cells to ionizing radiation is independent of p53 and cell cycle control but caused by the lack of caspase-3 and a caffeine-inhibitable event. Cancer Res 64 (2004) 7065-7072
13. Flamigni F., Guarnieri C., Marmiroli S., and Caldarera C.M. Inhibition of rat heart ornithine decarboxylase by basic peptides. Biochem J 222 (1985) 807-810
14. Fujita-Yamaguchi Y., Sacks D.B., and Donald J.M. Effect of basic polycations and proteins on purified insulin receptor. Biochem J 263 (1989) 813-822
15. 1 to S phase transition. J Cell Physiol 93 (1977) 81-87
16. Grunstein M. Histones as regulators of gene. Sci Am 267 (1992) 68B-74B
17. Ha H.C., Woster P.M., Yager J.D., and Casero Jr. R.A. The role of polyamine catabolism in polyamine-induced programmed cell death. Proc Natl Acad Sci U S A 94 (1997) 1557-1562
18. Hiemstra P.S., EisenHauen P.B., Harwig S.S., Vander Barselaar M.T., van Furth, and Lehrer R.I. Antimicrobial proteins of murine macrophages. Infect Immun 61 (1993) 3038-3046
19. Huber M., and Poulin R. Post translational cooperativity of ornithine decarboxylase induction by estrogens and peptide growth factors in human breast cancer cells. Mol Cell Endocrinol 117 (1996) 211-218
20. Janicke R.U., Sprengart M.L., Wati M.R., and Porter A.G. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J Biol Chem 273 (1998) 9357-9360
21. Kaczmerek L., Calabretta B., Ferrari S., and Riel J.K. Cell cycle dependent expression of human ornithine decarboxylase. J Cell Physiol 132 (1987) 545-551
22. Kleine T.J., Gladfelter A., Lewis P.N., and Lewis S.A. Histone induced damage of a mammalian epithelium: the conductive effect. Am J Physiol 268 (1995) C1114-C1125
23. Konishi A., Shimizu, Hiorta J., Takao T., Fan Y., Matsuako Y., et al. Involvement of histone H1.2 in apoptosis induced by DNA double strand breaks. Cell 114 (2003) 673-688
24. Konopinska D., Nawrocka E., Siemion I.Z., Slopek S., Szymaniec S.T., and Klonowska E. Partial sequence of histones with tuftsin activity. Int J Pept Protein Res 9 (1977) 71-77
25. Kubota S., Yamada T., Kamei S., and Seyama Y. Ornithine decarboxylase is directly involved in mouse mammary carcinoma cell invasion in vitro. Biochem Biophys Res Commun 208 (1995) 1106-1115
26. Kyprianou N., English H.F., Davidson N.E., and Isaacs J.T. Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation. Cancer Res 51 (1991) 162-166
27. Laster S.M., Wood J.C., and Goodin L.R. Tumor necrosis factor α induce both apoptotic and necrotic forms of cell lysis. J Immunol 14 (1988) 2629-2634
28. Leak A.M., and Woo P. Juvenile chronic arthritis, chronic iridocyclitis, and reactivity to histones. Ann Rheum Dis 50 (1991) 653-657
29. Leveque J., Foucher F., Havouis R., Desury D., Grall J.Y., and Moulinoux J.P. Benefits of complete polyamine deprivation in hormone responsive and hormone resistant MCF-7 human breast adenocarcinoma in vivo. Anticancer Res 20 (2000) 97-101
30. Manni A., Grove R., Kunselman S., and Aldaz M. Involvement of the polyamine pathway in breast cancer progression. Cancer Lett 92 (1995) 49-57
31. Manni A., Wechter R., Grove R., Wei L, Martel J., and Demers L. Polyamine profiles and growth properties of ornithine decarboxylase overexpressing MCF-7 breast cancer cells in culture. Breast Cancer Res Treat 34 (1995) 45-53
32. Manni A., Wechter R., Wei L., Heitjan D., and Demers L. Phenotypic features of breast cancer cells overexpressing ornithine-decarboxylase. J Cell Physiol 163 (1995) 129-136
33. Mossmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. J Immunol Methods 65 (1983) 55-63
34. Oberhammer F., Wilson J.W., Dive C., Morris I.D., Hickman J.A., Wakeling A.E., et al. Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J 12 (1993) 3679-3684
35. Pegg A.E. Polyamine metabolism and its importance in neoplastic growth and a target for chemotherapy. Cancer Res 48 (1988) 759-774
36. Pettersson T., Pukkala E., Teppo L., and Friman C. Increased risk of cancer patients with systemic lupus erythematosus. Ann Rheum Dis 51 (1992) 437-439
37. Rassmusen C., and Garen C. Activation of calmodulin dependent enzymes can selectively inhibited by histone H1. J Biol Chem 268 (1993) 23788-23791
38. Reichhart R., Zeppezauer M., and Jornvall H. Preparations of homeostatic thymus hormone consist predominantly of histones 2A and 2B and suggest additional histone functions. Proc Natl Acad Sci U S A 82 (1985) 4871-4875
39. Romero-Oliva G., Jacob G., and Allende J.E. Dual effect of lysine-rich polypeptides on the activity of protein kinase CK2. Cell Biochem 89 (2003) 348-355
40. Sambrook J., Fritsch E.F., and Manniatis T. Commonly used techniques in molecular cloning (1989), Cold Spring Harbor Press, New York p. E3-E11
41. Sheikh M.S., Garcia M., Pujol P., Fontana J.A., and Rochefort H. Why are estrogen receptor negative breast cancers more aggressive than the estrogen receptor positive breast cancers?. Invasion Metast 14 (1995) 329-336
42. Soule H.D., Vazquez J., Long A., Albert S., and Brennan M. A human cell line from pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 51 (1973) 1409-1413
43. Takahashi Y., Mai M., and Nishioka K. Alpha difluoromethylornithine induces apoptosis as anti-angiogenesis in the inhibition of tumor growth and metastasis in a human gastric cancer model. Int J Cancer 85 (2000) 243-247
44. Tsoneva I., Nikolova B., Georgieva M., Guenova M., Tomov T., Rols M.-P., et al. Induction of apoptosis by electrotransfer of positively charged proteins as cytochrome C and histone H1 into cells. Biochim Biophys Acta 1721 (2005) 55-64
45. Wesierska-Gadek J., Penner E., Lindner H., Hithcman E., and Sauermann G. Autoantibodies against different histone H1 subtypes in systemic lupus erythematosus sera. Arthritis Rheum 33 (1990) 1273-1278
46. van Leeuwen J.P., Bos M.P., and Herrmann-Erlee M.P. Modulatory function of protein kinase C in the activities of ornithine decarboxylase and in cAMP production in rat osteoblasts. J Cell Physiol 138 (1989) 548-554
47. Vani G., and Shyamaladevi C.S. Tumour suppressor activity of histone H1 in experimental breast mammary carcinoma. Ind J Pharmacol 32 (2000) 210-213
48. Vani G., Devipriya S., and Shyamaladevi C.S. Histone H1 modulates the immune status in experimental breast cancer. Chemotherapy 49 (2003) 252-256
49. Vani G., and Shyamaladevi C.S. Effect of histone H1 on estrogen receptor status in human breast cancer MCF 7 cells. Mol Cell Biochem 272 (2005) 151-155
50. Yuhas I.M., Li A.P., Martinez A.O., and Ladmanm A. A simplified method for production and growth of multicellular tumor spheroids. J Cancer Res 37 (1977) 3639-3643
51. Zeppezauer M, Reichhart R. Use of histone H1 and H2A:H2B dimers in therapeutic methods. US Patent 1989; 5,182,257.